Akero Therapeutics, Inc. (AKRO)
54.65
0.00 (0.00%)
USD |
NASDAQ |
Dec 10, 16:00
Akero Therapeutics Total Assets (Quarterly): 1.006B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 208.73B |
| Eli Lilly & Co. | 114.94B |
| Bristol Myers Squibb Co. | 96.89B |
| Adaptive Biotechnologies Corp. | 490.61M |
| Johnson & Johnson | 192.82B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 47.94M |
| Shareholders Equity (Quarterly) | 957.64M |
| Debt to Equity Ratio | 0.0012 |
| Current Ratio | 15.83 |
| Net Debt Paydown Yield | 0.18% |